JP2005516979A5 - - Google Patents

Download PDF

Info

Publication number
JP2005516979A5
JP2005516979A5 JP2003565227A JP2003565227A JP2005516979A5 JP 2005516979 A5 JP2005516979 A5 JP 2005516979A5 JP 2003565227 A JP2003565227 A JP 2003565227A JP 2003565227 A JP2003565227 A JP 2003565227A JP 2005516979 A5 JP2005516979 A5 JP 2005516979A5
Authority
JP
Japan
Prior art keywords
halogen
alkyl
optionally substituted
cyano
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003565227A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005516979A (ja
JP4069074B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/005782 external-priority patent/WO2003065789A2/en
Publication of JP2005516979A publication Critical patent/JP2005516979A/ja
Publication of JP2005516979A5 publication Critical patent/JP2005516979A5/ja
Application granted granted Critical
Publication of JP4069074B2 publication Critical patent/JP4069074B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003565227A 2002-02-08 2003-02-04 N−ビフェニルメチルアミノシクロアルカンカルボキサミド誘導体 Expired - Fee Related JP4069074B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35506202P 2002-02-08 2002-02-08
US41077502P 2002-09-12 2002-09-12
PCT/US2003/005782 WO2003065789A2 (en) 2002-02-08 2003-02-04 N-biphenylmethyl aminocycloalkanecarboxamide derivatives

Publications (3)

Publication Number Publication Date
JP2005516979A JP2005516979A (ja) 2005-06-09
JP2005516979A5 true JP2005516979A5 (cg-RX-API-DMAC7.html) 2006-03-23
JP4069074B2 JP4069074B2 (ja) 2008-03-26

Family

ID=27737482

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003565227A Expired - Fee Related JP4069074B2 (ja) 2002-02-08 2003-02-04 N−ビフェニルメチルアミノシクロアルカンカルボキサミド誘導体

Country Status (9)

Country Link
US (1) US7091380B2 (cg-RX-API-DMAC7.html)
EP (1) EP1476419B1 (cg-RX-API-DMAC7.html)
JP (1) JP4069074B2 (cg-RX-API-DMAC7.html)
AT (1) ATE316954T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003217728B2 (cg-RX-API-DMAC7.html)
CA (1) CA2473778A1 (cg-RX-API-DMAC7.html)
DE (1) DE60303441T2 (cg-RX-API-DMAC7.html)
ES (1) ES2256727T3 (cg-RX-API-DMAC7.html)
WO (1) WO2003065789A2 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI259079B (en) 2002-02-08 2006-08-01 Merck & Co Inc N-biphenyl(substituted methyl)aminocycloalkanecarboxamide derivatives
AU2003265674B2 (en) * 2002-08-29 2008-12-11 Merck & Co., Inc. N-biarylmethyl aminocycloalkanecarboxamide derivatives
JP2007501790A (ja) * 2003-08-07 2007-02-01 メルク エンド カムパニー インコーポレーテッド スルホニル置換n−(ビアリールメチル)アミノシクロプロパンカルボキサミド
CN1926136A (zh) * 2004-03-02 2007-03-07 默克公司 作为缓激肽拮抗剂的氨基环丙烷羧酰胺衍生物
EP1741444A1 (en) * 2005-07-05 2007-01-10 Jerini AG Kinin antagonists for treating bladder dysfunction
EP2520561B1 (en) 2007-06-08 2016-02-10 MannKind Corporation IRE-1A Inhibitors
TW200911761A (en) * 2007-08-29 2009-03-16 Boehringer Ingelheim Int New B1-antagonists
PE20121470A1 (es) 2007-10-26 2012-11-18 Univ California Compuestos de diarilhidantoina como antagonistas del receptor de androgeno
JP5629274B2 (ja) 2009-02-26 2014-11-19 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ブラジキニンb1アンタゴニストとしての化合物
EP2445909B1 (en) * 2009-06-02 2013-11-13 Boehringer Ingelheim International GmbH DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
US8937073B2 (en) * 2010-08-20 2015-01-20 Boehringer Ingelheim International Gmbh Disubstituted tetrahydrofuranyl compounds and their use as B1-receptor antagonists
US8592426B2 (en) * 2011-01-24 2013-11-26 Hoffmann—La Roche Inc. Aryl-benzocycloalkyl amide derivatives
KR101373705B1 (ko) * 2011-08-05 2014-03-14 동국대학교 산학협력단 신규한 바이페닐 유도체 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 포함하는 염증성 질환 또는 자가면역질환의 예방 또는 치료용 약학적 조성물
WO2013021044A1 (de) * 2011-08-11 2013-02-14 Bayer Intellectual Property Gmbh 1,2,4-triazolyl-substituierte ketoenole
TWI854164B (zh) * 2016-02-01 2024-09-01 美商百歐克斯製藥公司 苯并吡唑化合物及其類似物
US12023319B2 (en) 2016-12-23 2024-07-02 Bayer Pharma Aktiengesellschaft Carboxylic acid aromatic amides
JOP20190156B1 (ar) 2016-12-23 2023-09-17 Bayer Pharma AG أميدات عطرية لحمض الكربوكسيليك بصفتها مضادات لمستقبلة البراديكينين b1
WO2018114783A1 (en) 2016-12-23 2018-06-28 Bayer Pharma Aktiengesellschaft Tetrazole containing compounds
MX2020004557A (es) * 2017-11-02 2020-10-05 Calico Life Sciences Llc Moduladores de la vía de estrés integrada.
TWI832295B (zh) 2018-10-11 2024-02-11 美商嘉來克生命科學有限責任公司 整合應激路徑之前藥調節劑
IL291783A (en) * 2019-10-02 2022-06-01 Domain Therapeutics ep4 prostaglandin e2 receptor antagonists

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270317A (en) 1990-03-20 1993-12-14 Elf Sanofi N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
IL99372A0 (en) * 1990-09-10 1992-08-18 Ciba Geigy Ag Azacyclic compounds
US5208236A (en) 1992-09-23 1993-05-04 Schering Corporation N-(acylaminomethyl)glutaryl amino acids and use
PT655461E (pt) 1993-11-16 2000-11-30 Novartis Ag Derivados ciclicos de aminoacidos
WO1997011717A1 (en) 1995-09-27 1997-04-03 Novartis Ag Treatment of chronic progressive renal failure
FR2743562B1 (fr) 1996-01-11 1998-04-03 Sanofi Sa Derives de n-(arylsulfonyl) aminoacides, leur preparation, les compositions pharmaceutiques en contenant
US6433185B1 (en) 1996-01-11 2002-08-13 Sanofi-Synthelabo N-(arylsulphonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
DE69923676T2 (de) 1998-04-23 2006-01-12 Novartis Ag Bestimmte heteroaryl substituierte thiol inhibitoren von endothelin wechselnden enzymen
RU2000129510A (ru) 1998-04-23 2002-11-10 Новартис АГ (CH) Определенные тиольные ингибиторы эндотелинпревращающих ферментов
US20020052370A1 (en) * 2000-07-06 2002-05-02 Barber Christopher Gordon Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
DE10036121A1 (de) 2000-07-25 2002-02-07 Merck Patent Gmbh N-Substituierte-1-amino-1,1-dialkyl-carbonsäurederivate
TWI259079B (en) 2002-02-08 2006-08-01 Merck & Co Inc N-biphenyl(substituted methyl)aminocycloalkanecarboxamide derivatives

Similar Documents

Publication Publication Date Title
JP2005516979A5 (cg-RX-API-DMAC7.html)
JP2005517006A5 (cg-RX-API-DMAC7.html)
JP2005537323A5 (cg-RX-API-DMAC7.html)
JP2016525075A5 (cg-RX-API-DMAC7.html)
JP2016514718A5 (cg-RX-API-DMAC7.html)
NO20070032L (no) Hetroarylbenzamid-derivater for anvendelse som GLK-aktivatorer ved behandling av diabetes
JP5985611B2 (ja) 炎症および免疫関連用途のための化合物
JP2014507464A5 (cg-RX-API-DMAC7.html)
JP2007517010A5 (cg-RX-API-DMAC7.html)
JP2007512349A5 (cg-RX-API-DMAC7.html)
JP2012528166A5 (cg-RX-API-DMAC7.html)
JP2009533410A5 (cg-RX-API-DMAC7.html)
HRP20230789T1 (hr) Derivati benzhidroksamske kiseline kao selektivni inhibitori hdac6
RU2019130519A (ru) 4-пиридоновое соединение или его соль, фармацевтическая композиция и содержащий их состав
RU2005108667A (ru) Производные n-биарилметиламиноциклоалканкарбоксамида
JP2004521095A5 (cg-RX-API-DMAC7.html)
JP2018519323A5 (cg-RX-API-DMAC7.html)
CA2634676A1 (en) Trisubstituted amine compounds as inhibitors of cholesteryl ester transfer protein cetp
JP2007517044A5 (cg-RX-API-DMAC7.html)
JP2020516671A5 (cg-RX-API-DMAC7.html)
JP2010504913A5 (cg-RX-API-DMAC7.html)
JP2007524696A5 (cg-RX-API-DMAC7.html)
JP2004529925A5 (cg-RX-API-DMAC7.html)
RU2019132155A (ru) Ингибиторные соединения
EA200970656A1 (ru) Вич-ингибирующие 5,6-замещенные пиримидины